Resistance-associated substitutions and response to treatment in a chronic hepatitis C virus infected-patient: an unusual virological response case report

Background: Direct-Acting agents (DAAs) target and inhibit essential viral replication proteins. They have revolutionized the treatment of Hepatitis C virus (HCV) infection reaching high levels of sustained virologic response. However, the detection of basal resistance-associated substitutions (RASs...

Full description

Bibliographic Details

Main Author:	Aldunate Caramori, Fabián (author)
Other Authors:	Echeverría Chagas, Natalia (author), Chiodi, Daniela (author), López, Pablo (author), Sánchez-Cicerón, Adriana (author), Soñora, Martín (author), Cristina, Juan (author), Moratorio, Gonzalo (author), Hernández, Nelia (author), Moreno Karlen, María del Pilar (author)
Format:	article
Language:	English
Published:	2021
Subjects:	DAA therapy Hepatitis C virus RASs minority variants Relapse Case report
Online Access:	https://hdl.handle.net/20.500.12008/35752
Tags:	Add Tag No Tags, Be the first to tag this record!